Efficacy of leukotriene receptor antagonist in children with obstructive sleep apnea: A systematic review and meta-analysis
Keywords:
Leukotriene receptor antagonist, montelukast, sleep apnea, childrenAbstract
Background: Obstructive sleep apnea (OSA) is a common disease in children. The most common cause is adenotonsillar hypertrophy. Adenotonsillectomy is the first line therapy. However, there are complications such as bleeding and respiratory compromise. Leukotriene receptor antagonist is an anti-inflamatory medication which also use for treatment of OSA in children.
Objective: To conduct a systematic review and meta-analysis to evaluate the effect of leukotriene receptor antagonist (LTRA) on obstructive sleep apnea (OSA) in children.
Methods: Data source was a comprehensive search of MEDLINE, Scopus, Ovid, Web of Science, and the Cochrane Library both of which were reviewed in May 2018. Manual searches and subject matter expert inputs were also obtained. This review included studies assessing the efficacy of LTRA for the treatment of OSA in children, wherein apnea hypopnea indexes (AHI) were reported.
Results: A total of three studies (143 patients) met our inclusion criteria. Pooled random effects analysis demonstrated a statistically significant improvement of polysomnographic respiratory events, with average AHI reduction of 2.72 events per hour, [95% confidence interval (CI) (- 3.95, - 1.49); P < 0.0001] and overall increase in minimal arterial oxygen saturation of 3.3% [95% CI 1.78, 4.77); P < 0.0001] in favor of LTRA. Significant reduction in adenoidal-nasopharyngeal ratio (A/N ratio) in favor of LTRA of 0.21 [95% CI (- 0.25, - 0.17); P < 0.00001] was also demonstrated.
Conclusion: Leukotriene receptor antagonist provided benefits in children with OSA, by reducing AHI, increasing minimal arterial oxygen saturation and reducing adenoid size. Data were based on meta-analysis of control trials with 12 - 16 months of follow up.
Downloads
References
Kaditis AG, Finder J, Alexopoulos EI, Starantzis K, Tanou K, Gampeta S, et al. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol 2004;37:499-509.
https://doi.org/10.1002/ppul.20002
Li AM, So HK, Au CT, Ho C, Lau J, Ng SK, et al. Epidemiology of obstructive sleep apnoea syndrome in Chinese children: a two-phase community study. Thorax 2010;65:991-7.
https://doi.org/10.1136/thx.2010.134858
Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012;130:e714-55.
https://doi.org/10.1542/peds.2012-1672
Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 2008;5:242-52. https://doi.org/10.1513/pats.200708-135MG
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, et al. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 2008;51:84-91. https://doi.org/10.1161/HYPERTENSIONAHA.107.099762
Redline S, Amin R, Beebe D, Chervin RD, Garetz SL, Giordani B, et al. The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population. Sleep 2011;34:1509-17.
https://doi.org/10.5665/sleep.1388
Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:e69. https://doi.org/10.1542/peds.109.4.e69
Tauman R, Gulliver TE, Krishna J, Montgomery-Downs HE, O'Brien LM, Ivanenko A, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr 2006;149:803-8.
https://doi.org/10.1016/j.jpeds.2006.08.067
Guilleminault C, Huang YS, Glamann C, Li K, Chan A. Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol Head Neck Surg 2007;136:169-75.
https://doi.org/10.1016/j.otohns.2006.09.021
De Luca CG, Pacheco-Pereira C, Aydinoz S, Bhattacharjee R, Tan HL, Kheirandish-Gozal L, et al. Adenotonsillectomy complications: a meta-analysis. Pediatrics 2015;136:702-18.
https://doi.org/10.1542/peds.2015-1283
Marcus CL, Ward SL, Mallory GB, Rosen CL, Beckerman RC, Weese-Mayer DE, et al. Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea. J Pediatr 1995;127:88-94. https://doi.org/10.1016/S0022-3476(95)70262-8
Pirelli P, Saponara M, Guilleminault C. Rapid maxillary expansion in children with obstructive sleep apnea syndrome. Sleep 2004;27:761-6. https://doi.org/10.1093/sleep/27.4.761
Nazarali N, Altalibi M, Nazarali S, Major MP, FloresMir C, Major PW. Mandibular advancement appliances for the treatment of paediatric obstructive sleep apnea: a systematic review. Eur J Orthod 2015;37:618-26. https://doi.org/10.1093/ejo/cju101
McGinley B, Halbower A, Schwartz AR, Smith PL, Patil SP, Schneider H. Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics 2009;124:179-88.
https://doi.org/10.1542/peds.2008-2824
Pereira KD, Roebuck JC, Howell L. The effect of body position on sleep apnea in children younger than 3 years. Arch Otolaryngol Head Neck Surg 2005;131:1014-6. https://doi.org/10.1001/archotol.131.11.1014
Pereira KD, Rathi NK, Fatakia A, Haque SA, Castriotta RJ. Body position and obstructive sleep apnea in 8-12-month-old infants. Int J Pediatr Otorhinolaryngol 2008;72:897-900.
https://doi.org/10.1016/j.ijporl.2008.03.002
Andersen IG, Holm JC, Homoe P. Obstructive sleep apnea in obese children and adolescents, treatment methods and outcome of treatment - A systematic review. Int J Pediatr Otorhinolaryngol 2016;87:190-7. https://doi.org/10.1016/j.ijporl.2016.06.017
Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive sleep apnea in children. Cochrane Database Syst Rev 2011;(1):CD007074. https://doi.org/10.1002/14651858.CD007074.pub2
Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017;140:950-8.
https://doi.org/10.1016/j.jaci.2017.03.050
Tesse R, Borrelli G, Mongelli G, Mastrorilli V, Cardinale F. Treating pediatric asthma according guidelines. Front Pediatr 2018;6:234. https://doi.org/10.3389/fped.2018.00234
Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364-70. https://doi.org/10.1164/rccm.200408-1064OC
Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a doubleblind, placebo-controlled study. Pediatrics 2012;130:e575-80.
https://doi.org/10.1542/peds.2012-0310
Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for children with obstructive sleep apnea: results of a double-blind, randomized, placebo-controlled trial. Ann Am Thorac Soc 2016;13:1736-41.
https://doi.org/10.1513/AnnalsATS.201606-432OC
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
https://doi.org/10.1136/bmj.d5928
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. https://doi.org/10.1136/bmj.327.7414.557
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Int J Surg 2010;8:336-41. https://doi.org/10.1016/j.ijsu.2010.02.007
Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidalnasopharyngeal ratio. AJR Am J Roentgenol 1979;133:401-4.
https://doi.org/10.2214/ajr.133.3.401
Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D.Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006;130:143-8.
https://doi.org/10.1378/chest.130.1.143
Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, Snow A, Bhattacharjee R, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009; 135:1142-9. https://doi.org/10.1378/chest.08-2102
Goldbart AD, Goldman JL, Li RC, Brittian KR, Tauman R, Gozal D. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest 2004;126:13-8. https://doi.org/10.1378/chest.126.1.13
Kaditis AG, Ioannou MG, Chaidas K, Alexopoulos EI, Apostolidou M, Apostolidis T, et al. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 2008;134:324-31. https://doi.org/10.1378/chest.07-2746
Kar M, Altintoprak N, Muluk NB, Ulusoy S, Bafaqeeh SA, Cingi C. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol 2016;273:4111-7.
https://doi.org/10.1007/s00405-016-3983-8
Liming BJ, Ryan M, Mack D, Ahmad I, Camacho M. Montelukast and nasal corticosteroids to treat pediatric obstructive sleep apnea: A systematic review and meta-analysis. Otolaryngol Head Neck Surg 2019;160:594-602. https://doi.org/10.1177/0194599818815683
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
